WEC
AXSM icon

Winslow Evans & Crocker’s Axsome Therapeutics AXSM Stock Holding History

Winslow Evans & Crocker’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$27K Hold
330
– – 0.01% 720
2020
Q3 		$24K Hold
330
– – 0.01% 587
2020
Q2 		$27K Hold
330
– – 0.01% 556
2020
Q1 		$20K Hold
330
– – 0.01% 570
2019
Q4 		$36K Hold
330
– – 0.01% 557
2019
Q3 		$8K Hold
330
– – ﹤0.01% 842
2019
Q2 		$10K Hold
330
– – ﹤0.01% 808
2019
Q1 		$6K Buy
+330
New +$3.06K ﹤0.01% 915

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $186M AUM 51.17% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.6B AUM 47.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return